Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
349
-
Total 13F shares, excl. options
-
37.2M
-
Shares change
-
-704K
-
Total reported value, excl. options
-
$4.51B
-
Value change
-
-$68.3M
-
Put/Call ratio
-
0.98
-
Number of buys
-
188
-
Number of sells
-
-141
-
Price
-
$121.45
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2025
417 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 349 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 48.9M outstanding shares and own 75.95% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.18M shares), BlackRock, Inc. (3.79M shares), WELLINGTON MANAGEMENT GROUP LLP (1.33M shares), RTW INVESTMENTS, LP (1.12M shares), MACQUARIE GROUP LTD (1.08M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.04M shares), GEODE CAPITAL MANAGEMENT, LLC (998K shares), Invesco Ltd. (991K shares), STATE STREET CORP (943K shares), and FMR LLC (928K shares).
This table shows the top 349 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.